Thank you for your email. We are looking into your query and will get back
to you as quickly as possible. Please note, our response time may vary
depending on the nature of your request.

[1]Keep antibiotics working

[2]https://www.pharmac.govt.nz/keepantibiot...

**********************************************************************

This email and any files transmitted with it are confidential and

intended solely for the use of the individual or entity to whom they

are addressed. If you have received this email in error please notify

the system manager.

This footnote also confirms that this email message has been swept by

MIMEsweeper for the presence of computer viruses.

www.clearswift.com

**********************************************************************

References

Visible links
2. https://www.pharmac.govt.nz/keepantibiot...

hide quoted sections

Hello Scout

Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018.

In October 2016, the manufacturers proposed delisting Androderm 2.5 mg patch and providing Androderm 5 mg patch as a clinical alternative.

Clinical advice was sought from PHARMAC's Endocrinology Subcommittee in October 2016 which advised that the 5 mg patch would be a suitable clinical alternative. The Subcommittee advised that the usual dosage for patients is 5 mg and they are currently required to use two 2.5 mg patches daily. Injection and capsule presentations are available for patients who require a lower dose treatment as the patches cannot be cut.

I have checked the Medsafe website, and Androderm 2.5mg patches are still approved in New Zealand. The company is Teva Pharma, and their phone number is 0800 800 097. It may be worth contacting them to check if the 2.5mg patch is still available here.

I hope this information is helpful.

Kind regards

Jan Carey
PHARMAC

-----Original Message-----
From: Scout Barbour-Evans <[FOI #10510 email]>
Sent: Monday, 10 June 2019 6:36 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - Rationale for defunding of Androderm 2.5mg Patches

Tēnā koutou Pharmac;

I am writing under the Official Information Act to ask what the rationale was for defunding 2.5mg androderm patches. If memory serves me right this happened between 2016 and 2017, but I can not find the information on your website.

While I am aware that 5mg patches are still available in New Zealand, I know that this dose is excessive for many people requiring consistent testosterone therapy, and that patches containing gel such as these can not be split in half as many doctors recommend.

Ngā mihi nui,
Scout Barbour-Evans

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #10510 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.

This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.

www.clearswift.com
**********************************************************************

hide quoted sections